Asset Allocation

As of November 30, 2025.
Type % Net
Cash 31.21%
Stock 35.75%
Bond 33.04%
Convertible 0.00%
Preferred 0.00%
Other 0.00%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 84.07%
Mid 10.65%
Small 5.29%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 62.60%    % Emerging Markets: 6.19%    % Unidentified Markets: 31.21%

Americas 40.64%
34.45%
United States 34.45%
6.19%
Argentina 1.46%
Colombia 1.08%
Mexico 3.66%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 15.71%
United Kingdom 2.59%
13.12%
France 2.75%
Netherlands 1.10%
Norway 2.41%
Sweden 4.15%
Switzerland 2.72%
0.00%
0.00%
Greater Asia 12.43%
Japan 3.53%
7.05%
Australia 7.05%
1.85%
South Korea 1.85%
0.00%
Unidentified Region 31.21%

Bond Credit Quality Exposure

AAA 6.36%
AA 24.42%
A 11.92%
BBB 37.99%
BB 13.64%
B 0.00%
Below B 4.41%
    CCC 4.41%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 1.26%
Not Available 0.00%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
40.74%
Materials
21.14%
Consumer Discretionary
0.00%
Financials
19.60%
Real Estate
0.00%
Sensitive
38.45%
Communication Services
29.48%
Energy
0.00%
Industrials
0.00%
Information Technology
8.96%
Defensive
20.82%
Consumer Staples
5.97%
Health Care
14.84%
Utilities
0.00%
Not Classified
0.00%
Non Classified Equity
0.00%
Not Classified - Non Equity
0.00%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 20.91%
Corporate 54.54%
Securitized 0.00%
Municipal 13.80%
Other 10.75%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
6.33%
Less than 1 Year
6.33%
Intermediate
35.43%
1 to 3 Years
3.26%
3 to 5 Years
25.13%
5 to 10 Years
7.05%
Long Term
58.23%
10 to 20 Years
26.14%
20 to 30 Years
12.95%
Over 30 Years
19.14%
Other
0.00%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial